239 related articles for article (PubMed ID: 16420989)
1. [Beta-lactamases of Gram negative bacteria: never-ending clockwork!].
Philippon A; Arlet G
Ann Biol Clin (Paris); 2006; 64(1):37-51. PubMed ID: 16420989
[TBL] [Abstract][Full Text] [Related]
2. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
Pfeifer Y; Cullik A; Witte W
Int J Med Microbiol; 2010 Aug; 300(6):371-9. PubMed ID: 20537585
[TBL] [Abstract][Full Text] [Related]
3. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM).
Cuzon G; Naas T; Bogaerts P; Glupczynski Y; Nordmann P
J Antimicrob Chemother; 2012 Aug; 67(8):1865-9. PubMed ID: 22604450
[TBL] [Abstract][Full Text] [Related]
5. [Development of Beta-lactamase resistance in enterobacteria].
Koren J; Vaculíková A
Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):103-7. PubMed ID: 17051471
[TBL] [Abstract][Full Text] [Related]
6. Minor extended-spectrum beta-lactamases.
Naas T; Poirel L; Nordmann P
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():42-52. PubMed ID: 18154527
[TBL] [Abstract][Full Text] [Related]
7. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and diversity of integrons and beta-lactamase genes among ampicillin-resistant isolates from estuarine waters.
Henriques IS; Fonseca F; Alves A; Saavedra MJ; Correia A
Res Microbiol; 2006 Dec; 157(10):938-47. PubMed ID: 17125975
[TBL] [Abstract][Full Text] [Related]
9. Defining an extended-spectrum beta-lactamase.
Livermore DM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():3-10. PubMed ID: 18154524
[TBL] [Abstract][Full Text] [Related]
10. Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
Jones RN; Sader HS; Fritsche TR
Diagn Microbiol Infect Dis; 2005 May; 52(1):71-4. PubMed ID: 15878447
[TBL] [Abstract][Full Text] [Related]
11. [Beta-lactamases and their role in resistance. PART 2: beta-lactamases in 21st century].
Bedenić B
Lijec Vjesn; 2005; 127(1-2):12-21. PubMed ID: 16145868
[TBL] [Abstract][Full Text] [Related]
12. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
Hrabák J
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
[TBL] [Abstract][Full Text] [Related]
13. [Gram-negative bacteriae with resistance to carbapenems].
Nordmann P
Med Sci (Paris); 2010 Nov; 26(11):950-9. PubMed ID: 21106177
[TBL] [Abstract][Full Text] [Related]
14. Carbapenemases: molecular diversity and clinical consequences.
Poirel L; Pitout JD; Nordmann P
Future Microbiol; 2007 Oct; 2(5):501-12. PubMed ID: 17927473
[TBL] [Abstract][Full Text] [Related]
15. New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance.
Lee JH; Bae IK; Lee SH
Med Res Rev; 2012 Jan; 32(1):216-32. PubMed ID: 20577973
[TBL] [Abstract][Full Text] [Related]
16. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
Walsh TR
Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():2-9. PubMed ID: 16209700
[TBL] [Abstract][Full Text] [Related]
17. beta-Lactam resistance and beta-lactamases in bacteria of animal origin.
Li XZ; Mehrotra M; Ghimire S; Adewoye L
Vet Microbiol; 2007 Apr; 121(3-4):197-214. PubMed ID: 17306475
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of tigemonam dicholate (SQ 30836) and interaction with beta-lactamases of gram-negative bacteria.
Raimondi A; Cocuzza CE
J Chemother; 1989 May; 1 Suppl 2():13-21. PubMed ID: 2809698
[TBL] [Abstract][Full Text] [Related]
20. [Resistance to the latest beta-lactams: mechanisms of acquisition and spread of resistance in Enterobacteriaceae].
Michel-Briand Y
Bull Acad Natl Med; 2007 Jan; 191(1):35-50; discussion 50-1. PubMed ID: 17645106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
